Press review
Media
Press articles and media passages dealing with cases of meningiomas linked to Androcur, Lutéran, Lotényl, of testimonies and actions in justices of the victims, of scientific publications.
December 21, 2024
News
Media
Help scandal on the progestogen Androcur: Emmanuelle recounts her "trying but essential" fight
November 24, 2024
News
Legal procedures
Media
Androcur: Amavea files a complaint against X for endangering others and aggravated deception
Press contact
Emmanuelle Huet-Mignaton
contact@amavea.org
06 07 58 67 96
The press kit is available for free download.
-
Revue prescribed January 2023: Let's talk more about macro-progestins and their risks
Read moreThe journal PRESCRIRE, the only independent medical journal, published our letter in its FORUM section…
: Revue prescribed January 2023: Let's talk more about macro-progestins and their risks -
Paris Match: Androcur- The nightmare medication- The victims revolt
Read morehttps://www.parismatch.com/actu/sante/scandale-sanitaire-les-victimes-de-landrocur-se-revoltent-219684 Prescribed for endometriosis, this molecule can cause brain tumors. Health authorities…
: Paris Match: Androcur- The nightmare medication- The victims revolt -
Revue prescribed November 2022: meningiomas and progestins (continued)
Read more : Revue prescribed November 2022: Meningiomas and progestins (continued) -
ANSM ANDROCUR (Cyproterone acetate): the measures taken since 2018 have allowed a clear reduction in the risk of meningioma
Read morehttps://ansm.sante.fr/actualites/androcur-acetate-de-cyproterone-les-mesures-prises-depuis-2018-ont-permis-une-nette-reduction-du-risque-de-meningiome AMELI, the French National Health Insurance website, also provides information on Androcur and generics: reduction of…
: ANSM Androcur (Cyproterone acetate): the measures taken since 2018 have made a clear reduction in the risk of meningioma
